Capabilities · Analytical & stability services

Raw-material & finished-product testing

A proposed service scope for routine material evaluation, connecting sample receipt, analytical execution, results generation and specification assessment.

PlannedCatalogue scope

Illustrative unbranded autosampler vial detail.
Illustrative unbranded autosampler vial detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Raw-material and finished-product testing is presented as a planned service domain. The material identity, safety parameters and approved product specification would set the required scope.

While the initial plan documents formulation modules, routine analytical testing represents a proposed catalogue expansion. This domain would need formal scope confirmation before potential initiation.

Sampling logistics and laboratory testing are distinct considerations. Evaluating physical or chemical properties does not imply that materials could be sampled under unclassified environmental conditions.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Active ingredientsSmall-molecule active ingredientsProposed testing for identity, purity and fundamental chemical properties.Catalogue scopePlanned
Excipient materialsPlanned evaluation against relevant pharmacopoeial monographs or agreed specifications.Catalogue scopePlanned
Finished productsAnalytical assessment proposed for final presentations before any disposition decision.Catalogue scopePlanned
Packaging componentsPrimary packagingPlanned physical checks for proposed primary container and closure systems.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Sample receipt and registration

Record the submitted material, confirm transport conditions and establish appropriate laboratory storage.

02 · Process stage

Planned

Testing schedule assignment

Allocate the required analytical procedures to laboratory workstreams based on material stability.

03 · Process stage

Planned

Reagent and standard preparation

Prepare the necessary analytical solutions and reference materials for the testing session.

04 · Process stage

Planned

Instrumental and wet chemistry

Perform the scheduled analytical steps according to approved methodology and pharmacopoeial requirements.

05 · Process stage

Planned

Data processing and review

Calculate analytical results, perform secondary technical checks and evaluate unexpected procedural outcomes.

06 · Process stage

Planned

Specification assessment and reporting

Compare the verified results against formal acceptance criteria and generate analytical documentation.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Microbiological testing

Methods, materials and facility conditions relevant to the proposed activity.

Explore proposed scope

02PlannedCatalogue scope

Impurities & extractables / leachables

Product, material and packaging-related analytical questions.

Explore proposed scope

03PlannedCatalogue scope

Manufacturing & quality documentation

Controlled technical records for the intended manufacturing scope.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Material and specifications
Product details, approved acceptance limits and formal analytical test procedures.
Facility and systems
Qualified laboratory areas, calibrated analytical equipment and an approved testing scope.
Method suitability
Validation evidence confirming the intended methodology is suitable for the material.
Quality responsibilities
Out-of-specification procedures, data integrity controls and defined formal reporting responsibilities.
Regulatory context
Applicable testing guidance and relevant regulatory status of the submitted material.
Technical agreement
Agreed laboratory boundaries, subcontracting limits and responsibilities for any material evaluation.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating laboratory testing service.

Would this scope include microbiological assessments?

No. The proposed domain primarily targets chemical and physical analytical properties. Microbiological evaluation would require a separate technical discussion.

What information helps define the question?

Identify the material type, governing specification, relevant compendial references and the technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, laboratory scope, permissions, methodological evidence and a formal agreement would need to be established before any testing commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma